CTAS
Cintas Corporation
CTAS's fundamentals are strong: it turned 18% of its revenue into free cash flow and revenue grew 9.5%. At 45x earnings, it's trading above its usual 39x. Analysts expect earnings growth.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
CTAS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
CTAS's revenue, profitability, cash flow and balance sheet are all currently healthy.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CTAS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 35x | $179 | -21% |
| Fair | 39x | $198 | -13% |
| Forward | 40x | $228 | — |
| Current | 45x | $228 | — |
| Expensive | 47x | $239 | +4.9% |
Historical ranges are pointers, not guarantees.
CTAS's PE is in its expensive range at 45x. If earnings grow as analysts expect, today's price would be 40x next year's earnings, in its fair range.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
CTAS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for CTAS, with profitability improving.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CTAS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.71 | +13% |
| Q3 2026 | $5.07 | +13% |
| Q2 2026 | $4.91 | +12% |
| Q1 2026 | $4.73 | +9.5% |
| Q4 2025 | $4.62 | +11% |
| Q3 2025 | $4.50 | +14% |
| Q2 2025 | $4.40 | +16% |
| Q1 2025 | $4.32 | +19% |
| Q4 2024 | $4.15 | +20% |
CTAS has the stronger earnings trend. Trailing diluted EPS is up 13% for CTAS versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
CTAS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3B | +11% |
| Q2 2026 | $2.9B | +8.9% |
| Q1 2026 | $2.8B | +8.9% |
| Q4 2025 | $2.8B | +9.3% |
| Q3 2025 | $2.7B | +8.7% |
| Q2 2025 | $2.7B | +8% |
| Q1 2025 | $2.6B | +8.4% |
| Q4 2024 | $2.6B | +7.8% |
CTAS's revenue has grown year over year for 22 quarters in a row: $3B last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +0.9 points |
| Q2 2026 | 23% | +0.8 points |
| Q1 2026 | 23% | -0.2 points |
| Q4 2025 | 23% | +0.3 points |
| Q3 2025 | 23% | +0.3 points |
| Q2 2025 | 22% | +0.2 points |
| Q1 2025 | 23% | +1.7 points |
| Q4 2024 | 23% | +2.1 points |
CTAS has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over CTAS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
CTAS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464.8M | +49% |
| Q2 2026 | $613.1M | +18% |
| Q1 2026 | $530.6M | +1.6% |
| Q4 2025 | $425M | +25% |
| Q3 2025 | $312.5M | -16% |
| Q2 2025 | $521.1M | -12% |
| Q1 2025 | $522.1M | -5.1% |
| Q4 2024 | $340M | +14% |
CTAS has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
CTAS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -1.9M shares |
| 1 year | -1.2% | -5M shares |
| 3 years | -2.4% | -10M shares |
| 5 years | -4.6% | -19.5M shares |
| Available history | -5.8% | -25.1M shares |
CTAS has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $315.7M |
| Q2 2026 | $18.9M |
| Q1 2026 | $31.6M |
| Q4 2025 | $635.6M |
| Q3 2025 | $266.1M |
| Q2 2025 | $256.7M |
| Q1 2025 | $26.6M |
| Q4 2024 | $36.7M |
CTAS spent $1B buying back its own shares over the past year, up 71% from the year before.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CTAS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.8x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Very low |
CTAS's net debt is less than a year of its operating earnings (EBITDA).
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CTAS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.7 | Neutral |
| Stochastic | 80.2 | Overbought |
CTAS's weekly RSI is 69 (neutral) and its Stochastic is 80 (overbought).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CTAS PE vs Industrials Sector
| Metric | CTAS | Sector median | Relative |
|---|---|---|---|
| PE | 45x | 24x | 87% above |
| PE % | 77 | 58 | 19 pts above |
CTAS is trading at 45x earnings, a 87% premium to the Industrials sector's median of 24x.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
CTAS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $212.9 | 6.9% above |
| 20 week MA | $204.5 | 11% above |
| 50 week MA | $191.7 | 19% above |
| 100 week MA | $198.1 | 15% above |
| 200 week MA | $175.2 | 30% above |
CTAS has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
CTAS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $67.3 | $84.6 | +26% |
| 2021 | $84.6 | $108.8 | +29% |
| 2022 | $108.8 | $114.3 | +5.1% |
| 2023 | $114.3 | $150.7 | +32% |
| 2024 | $150.7 | $183.4 | +22% |
| 2025 | $183.4 | $191.1 | +4.2% |
| 2026 YTD | $191.1 | $227.5 | +19% |
CTAS has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.